Stay updated on BXCL701 Combo in mCRPC: SCLC/Adeno Clinical Trial
Sign up to get notified when there's something new on the BXCL701 Combo in mCRPC: SCLC/Adeno Clinical Trial page.

Latest updates to the BXCL701 Combo in mCRPC: SCLC/Adeno Clinical Trial page
- Check3 days agoChange DetectedThe clinical trial page now displays the study record for BXCL701 and pembrolizumab in patients with metastatic castration-resistant prostate cancer, including study design, eligibility, locations, and outcome measures. The record indicates the study is completed and is no longer recruiting.SummaryDifference72%

- Check10 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page content still shows a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check24 days agoChange DetectedThe footer's site revision label changes from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the previous study record content. This indicates a permissions/access issue preventing viewing the study details on ClinicalTrials.gov.SummaryDifference21%

Stay in the know with updates to BXCL701 Combo in mCRPC: SCLC/Adeno Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BXCL701 Combo in mCRPC: SCLC/Adeno Clinical Trial page.